drugset / Trial / NCT04131829
Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD
Phase 1/2
Recruiting
100 enrolled
Yale University
National Institute of Mental Health (NIMH) · collab
RandomizedParallel-groupDouble-blindBasic science
Summary
The proposed randomized, double-blind research study will use functional magnetic resonance neuroimaging using state-of-the-art HCP acquisition protocols and analytic pipelines, to identify predictors and correlates of response to an accepted first-line pharmacological treatment for obsessive-compulsive disorder.
Timeline
- Start
- 2019-10-14
- Primary completion
- 2026-06-30
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluoxetine | Small molecule | — | — |